Unit Outline
CSA306
Therapeutics in Practice 3B
Health Study Period 2, 2024
Chanelle Brodie
School of Pharmacy and Pharmacology
College of Health and Medicine
CRICOS Provider Code: 00586B

Unit Coordinator
Chanelle Brodie
Email: Chanelle.Brodie@utas.edu.au
 

What is the Unit About?
Unit Description
CSA306 (Therapeutics in Practice 3B) is designed to build upon your existing knowledge of pharmacology, physiology, microbiology and evidence-based health, in order to develop the clinical knowledge and skills necessary to deliver pharmaceutical care. The unit covers the pathophysiology and therapeutic management of common diseases. In CSA306, specific topics include hepatology, neurology, pain, psychiatry, gastroenterology and rheumatology. An emphasis is placed on the application of knowledge to evaluate and advise upon pharmacotherapy in clinical situations. Although CSA306 and CSA322 (Therapeutics in Practice 3A) are separate units, the learning derived from one is complementary to the other. CSA306 carries a weighting of 12.5% (i.e. 12.5 credit points).
Intended Learning Outcomes
As per the Assessment and Results Policy 1.3, your results will reflect your achievement against specified learning outcomes.
On completion of this unit, you will be able to:
1.
Apply an understanding of pathophysiology and epidemiology to the pharmacotherapeutic management (including self-care) of disease and illness of local, national and international importance.
2.
Apply professional problem-solving skills to identify critical issues, conceptualise problems, use relevant information and formulate a range of solutions in relation to the provision of medicines or health advice
3.
Apply an evidence-based decision framework in the management of medicines and the use of healthcare interventions.
Requisites
REQUISITE TYPE
REQUISITES
Pre-requisite
CSA322
Co-requisite
CSA357
Alterations as a result of student feedback
In response to the feedback from previous student cohort, changes have been made whic includes adjustments to the teaching pattern and assessments. As always, the teaching team will greatly appreciate your feedback both informally during the delivery of the unit in 2024, and formally through the University of Tasmania’s eVALUate surveys following your completion of the unit.
 
 

Teaching arrangements
ATTENDANCE MODE
TEACHING TYPE
LEARNING ACTIVITY
CONTACT HOURS
FREQUENCY
On Campus
Workshop
3-hour workshops weekly
3
Weekly
Clinical or Professional Practice
15 hours of hospital based clinical rounds throughout the study period.
15
Study Period 1 time
Independent Learning
6 hours self-directed online learning activities weekly
6
Weekly
Attendance / engagement expectations
If your unit is offered On campus, it is expected that you will attend all on-campus and onsite learning activities. This is to support your own learning and the development of a learning community within the unit. If you are unable to attend regularly, please discuss the situation with your course coordinator and/or our UConnect support team.

If your unit is offered Online or includes online activities, it is expected you will engage in all those activities as indicated in the Unit Outline or MyLO, including any self-directed learning.

If you miss a learning activity for a legitimate reason (e.g., illness, carer responsibilities) teaching staff will attempt to provide alternative activities (e.g., make up readings) where it is possible.
 
 
 
 

How will I be Assessed?
 
For more detailed assessment information please see MyLO.
Assessment schedule
ASSESSMENT TASK #
ASSESSMENT TASK NAME
DATE DUE
WEIGHT
LINKS TO INTENDED LEARNING OUTCOMES
Assessment Task 1:
In-workshop oral assessments
Week 1
15 %
LO1, LO2, LO3
Assessment Task 2:
Mid-semester written test
Week 5
20 %
LO1, LO2, LO3
Assessment Task 3:
End of semester oral exam
Exam Period
25 %
LO1, LO2, LO3
Assessment Task 4:
End of semester written Exam
Exam Period
40 %
LO1, LO2, LO3
 
Assessment details
Assessment Task 1: In-workshop oral assessments
Task Description:
During workshops you will do an oral assessment. The top 3 marks from the oral assessments will count towards this assessment task.
Task Length:
10 minutes
Due Date:
Week 1
Weight:
15 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Apply knowledge and understanding of therapeutic principles, epidemiology and pathophysiology of disease states covered prior to the workshop.
LO1, LO2, LO3
2
Display an understanding of medications used in specific diseases, their adverse effects and the patient cohorts they are suitable for.
LO1, LO2, LO3
3
Apply problem-solving skills and evidence based therapeutic knowledge to specific cases
LO1, LO2, LO3
 
Assessment Task 2: Mid-semester written test
Task Description:
You will be required to sit a face to face mid-semester test: comprising multiple choice questions (MCQs) and short-answer/case-based question
Task Length:
50 minutes
Due Date:
Week 5
Weight:
20 %
 
 

CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Apply knowledge and understanding of therapeutic principles, epidemiology and pathophysiology of disease states covered prior to the mid-semester test.
LO1, LO2, LO3
2
Display an understanding of medications used in specific diseases, their adverse effects and the patient cohorts they are suitable for.
LO1, LO2, LO3
3
Apply problem-solving skills and evidence based therapeutic knowledge to specific cases.
LO1, LO2, LO3
 
Assessment Task 3: End of semester oral exam
Task Description:
You will be required to sit an end of semester oral exam -comprising verbalised questions testing your ability to verbally communicate and apply appropriate therapeutic principles in a conversational setting.
Task Length:
15 minutes + 3 minutes reading time
Due Date:
Exam Period
Weight:
25 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Apply knowledge and understanding of therapeutic principles, epidemiology and pathophysiology of disease states covered prior to the exam.
LO1, LO2, LO3
2
Display an understanding of medications used in specific diseases, their adverse effects, and the patient cohorts they are suitable for.
LO1, LO2, LO3
3
Apply problem-solving skills and evidence based therapeutic knowledge to specific cases.
LO1, LO2, LO3
 
Assessment Task 4: End of semester written Exam
Task Description:
You will be required to sit a face to face exam: comprising multiple choice questions (MCQs) and short-answer/case-based questions

This is a hurdle exam.
Task Length:
2 hours
Due Date:
Exam Period
Weight:
40 %
 
CRITERION #
CRITERION
MEASURES INTENDED
LEARNING OUTCOME(S)
1
Apply knowledge and understanding of therapeutic principles, epidemiology and pathophysiology of disease states covered prior to the exam.
LO1, LO2, LO3
2
Display an understanding of medications used in specific diseases, their adverse effects and the patient cohorts they are suitable for.
LO1, LO2, LO3
3
Apply problem-solving skills and evidence based therapeutic knowledge to specific cases.
LO1, LO2, LO3
 
 
 

How your final result is determined
To pass this unit, you need to demonstrate your attainment of each of the Intended Learning Outcomes, achieve a final unit grade of 50% or greater, and pass any hurdle tasks.
Submission of assignments
Where practicable, assignments should be submitted to an assignment submission folder in MYLO. You must submit assignments by the due date or receive a penalty (unless an extension of time has been approved by the Unit Coordinator). Students submitting any assignment in hard copy, or because of a practicum finalisation, must attach a student cover sheet and signed declaration for the submission to be accepted for marking.
Academic integrity
Academic integrity is about acting responsibly, honestly, ethically, and collegially when using, producing, and communicating information with other students and staff members.

In written work, you must correctly reference the work of others to maintain academic integrity. To find out the referencing style for this unit, see the assessment information in the MyLO site, or contact your teaching staff. For more detail about Academic Integrity, see
Important Guidelines & Support.
Requests for extensions
If you are unable to submit an assessment task by the due date, you should apply for an extension.
 
A request for an extension should first be discussed with your Unit Coordinator or teaching support team where possible. A request for an extension must be submitted by the assessment due date, except where you can provide evidence it was not possible to do so. Typically, an application for an extension will be supported by documentary evidence: however, where it is not possible for you to provide evidence please contact your Unit Coordinator.
 
The Unit Coordinator must notify you of the outcome of an extension request within 3 working days of receiving the request.
Late penalties
Assignments submitted after the deadline will receive a late penalty of 5% of the original available mark for each calendar day (or part day) that the assignment is late. Late submissions will not be accepted more than 10 calendar days after the due date, or after assignments have been returned to other students on a scheduled date, whichever occurs first. Further information on Late Penalties can be found on the Assessments and Results Procedure.
Review of results and appeals
You are entitled to ask for a review of the marking and grading of your assessment task if there is an irregularity in the marking standards or an error in the process for determining the outcome of an assessment. Details on how to request a review of a mark for an assignment are outlined in the Review and Appeal of Academic Decisions Procedure.
 
 

 
 

Required Resources
Required reading materials
 
 
Recommended reading materials
Students are recommended to view the following online resources via the library website:
DiPiro et al. Pharmacotherapy: A Pathophysiologic Approach. McGraw-Hill Medical (12th Edition)
In addition to the recommended online textbook, students will be signposted to a variety of other material relevant to the area of study. Links will be provided to these materials through MyLO where possible. Most of these materials will be available online, either freely accessible or through the University library.
Students will also find the following e-resources (available via EPOCH) highly valuable for CSA306 and related units:
• Australian Medicines Handbook (AMH)
• Therapeutic Guidelines (TG), Therapeutic Guidelines Ltd
• UpToDate
 
Other required resources